Cure My Disease

Don't miss your cure!

 Log in / Sign up

Gut bacteria clues could spot liver damage early

NCT ID NCT07284862

Completed Knowledge-focused Sponsor: Zhujiang Hospital Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study looked at whether fragments from gut bacteria (called peptidoglycans) are linked to alcohol-related liver disease. 40 participants with liver cirrhosis provided stool samples to measure these fragments. The goal was to see if these fragments could be used as a screening or diagnostic tool for the disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could point toward new ways to screen for or diagnose alcohol-related liver disease using stool samples.
What could go wrong
This is a small, completed observational study (40 people) that only looks for a link, not a treatment. The findings may not apply to everyone with the disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALCOHOL-ASSOCIATED LIVER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

alcoholic liver disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALCOHOL-ASSOCIATED LIVER DISEASE

Contacts and locations

Locations

  • Zhujiang Hospital of Southern Medical University

    Guangzhou, Guangdong, 510000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.